Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News XOMA Royalty Corporation XOMA

Alternate Symbol(s):  XOMAP | XOMAO

Healthcare Biotechnology
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales... see more

Current News (NDAQ:XOMA)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

ACCESS Newswire 17 hours ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

GlobeNewswire 1 day ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

ACCESS Newswire 2 days ago

XOMA Royalty Announces CFO Transition

GlobeNewswire 2 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

ACCESS Newswire 3 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

ACCESS Newswire 4 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

ACCESS Newswire 5 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

ACCESS Newswire 7 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

GlobeNewswire 8 days ago
View More News ››

Opinion & Analysis (NDAQ:XOMA)

Stock picks and coal plays Cotton likes

J.W. Cotton May 22, 2009
View More Opinion ››

Bullboard Posts (NDAQ:XOMA)

THE WILD SLIDE DOWN ! WELL ON ITS WAY . PUMP AND DUMP .

LOOK OUT BELOW !!!!!!!!!!!!!!!!!!!!!!! FC
FirstClass - November 9, 2015

Congrats...

To those that got in.
Stocktrader4bux - November 5, 2015

Great time to jump in...

About to BLAST OFF!!!
Stocktrader4bux - November 5, 2015

Volume...

Speaks Volumes.
Stocktrader4bux - November 3, 2015

RE: RE: RE: FDA designates XOMA 052 orphan drug fo

awfully quiet now.... ----------Original Message Posted 8/14/2010 12:20:59 PM---------- Hey Jeffi,I have XOMA for a lotto in my...
dipc - December 28, 2010

RE: RE: RE: FDA designates XOMA 052 orphan drug fo

Hey Jeffi,I have XOMA for a lotto in my portfolio.Diltution is the biggest problem for XOMA shareholders so far.
sparkasse - August 14, 2010
View more Bullboard ››

Mink Ventures Corp.

Mink Ventures Corp.

Mink Ventures Corporation engages in the acquisition, exploration, and development of mineral property interests in Canada ...
View More »

Podcasts